Clinical implication and immunological landscape analyses of <scp>ANLN</scp> in pan‐cancer: A new target for cancer research

Abstract

ANLN may serve as a prognostic biomarker for pan-cancer. ANLN upregulation is associated with higher TMB, MSI, and immune cell infiltration in multiple types of tumors, shedding new light for cancer treatment.